Medicines are a vital part of modern health care. The question of how to provide patients with access to innovative medicines, in a way that the NHS can afford, has been discussed by policy-makers, politicians and industry for many years. In 2018, The King’s Fund released a policy report discussing some of the key issues, but the situation is evolving and the National Institute for Health and Care Excellence (NICE) is currently reviewing how it appraises new medicines.
This free online event explored the current medicines landscape and highlighted some of the key challenges to patients accessing medicines in England. The discussion included patient, industry and system perspectives on the medicines access process.
Watch on demand
- Director of Policy
Paul CatchpoleValue and Access Director, The Association of the British Pharmaceutical Industry (ABPI)
Bradley PricePolicy and Public Affairs Manager, Sarcoma UK
Dominic PivonkaHead of Health Technology Assessments and Pricing, AbbVie
Nina PinwillHead of Commercial Operations and Acting Commercial Medicines Director (due to COVID-19), NHS England and NHS Improvement